Skip to main content
editorial
. 2025 Jun 13;13(6):1456. doi: 10.3390/biomedicines13061456
AD Alzheimer’s disease
ADHD attention-deficit/hyperactivity disorder
AI artificial intelligence
CB1 cannabinoid receptor type 1
CSF cerebrospinal fluid
HPA hypothalamic–pituitary–adrenal
5-HT 5-hydroxytryptamine
5-HT1A 5-hydroxytryptamine receptor type 1A
5-HTP 5-hydroxytryptophan
IL interleukin
MAO-A monoamine oxidase A
miR-200b-3p microRNA 200b family subtype the 3′ strand
OCD obsessive–compulsive disorder
PET positron emission tomography
p-tau217/231 phosphorylated tau protein at threonine 217 and threonine 231
TAARs trace amine-associated receptors
TNF tumor necrosis factor